Publications by authors named "Douglas Hackenyos"

Claim this Profile
A
Absence of Anti-Babesia microti antibody in commercial intravenous immunoglobulin (IVIG).
Julia Kostka, Anu S Maharjan, Sanjai Kumar, Douglas Hackenyos, Peter J Krause

PLoS Negl Trop Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of patients' understanding of and adherence to oral anticancer medication (OAM): Results of a cross-sectional institutional pilot study.
Angie Mae Rodday, Douglas Hackenyos, Raisa Masood, Nicole Savidge, Mingqian Lin

J Oncol Pharm Pract· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing patients' understanding of and adherence to oral anticancer medication: Results of a longitudinal pilot intervention.
Mingqian Lin, Douglas Hackenyos, Nicole Savidge, Ruth Ann Weidner, Rachel Murphy-Banks

J Oncol Pharm Pract· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualitative and quantitative variations in liver function thresholds among clinical trials in cancer: a need for harmonization.
Edwin Wang, Fei Song, Jessica K Paulus, Douglas Hackenyos, Paul Mathew

Cancer Chemother Pharmacol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imprecise Kidney Function Thresholds in Cancer Clinical Trials and the Potential for Harm.
Edwin Wang, Jessica K Paulus, Douglas Hackenyos, Lesley A Inker, Andrew S Levey

JNCI Cancer Spectr· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis